Home LiteratureArticle Details
PMID: 17431505 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Aberrant activation of AMP-activated protein kinase remodels metabolic network in favor of cardiac glycogen storage.

The Journal of clinical investigation ·Vol. 117 ·No. 5 ·2007-05-00 ·Pages 1432-9

Luptak I, Shen M, He H, Hirshman MF, Musi N, Goodyear LJ, Yan J, Wakimoto H, Morita H, Arad M, Seidman CE, Seidman JG, Ingwall JS, Balschi JA, Tian R

Abstract

AMP-activated protein kinase (AMPK) responds to impaired cellular energy status by stimulating substrate metabolism for ATP generation. Mutation of the gamma2 regulatory subunit of AMPK in humans renders the kinase insensitive to energy status and causes glycogen storage cardiomyopathy via unknown mechanisms. Using transgenic mice expressing one of the mutant gamma2 subunits (N488I) in the heart, we found that aberrant high activity of AMPK in the absence of energy deficit caused extensive remodeling of the substrate metabolism pathways to accommodate increases in both glucose uptake and fatty acid oxidation in the hearts of gamma2 mutant mice via distinct, yet synergistic mechanisms resulting in selective fuel storage as glycogen. Increased glucose entry in the gamma2 mutant mouse hearts was directed through the remodeled metabolic network toward glycogen synthesis and, at a substantially higher glycogen level, recycled through the glycogen pool to enter glycolysis. Thus, the metabolic consequences of chronic activation of AMPK in the absence of energy deficiency is distinct from those previously reported during stress conditions. These findings are of particular importance in considering AMPK as a target for the treatment of metabolic diseases.

MeSH Terms
AMP-Activated Protein Kinases Amino Acid Substitution/genetics Animals Cardiomyopathies/genetics,metabolism Disease Models, Animal Energy Metabolism/genetics Enzyme Activation/genetics Glycogen/metabolism Glycogen Storage Disease/enzymology,genetics,metabolism Humans Mice Multienzyme Complexes/biosynthesis,genetics,metabolism Myocardium/metabolism Oxidative Stress/genetics Protein Serine-Threonine Kinases/biosynthesis,genetics,metabolism Substrate Cycling/genetics Up-Regulation/genetics
Chemicals
Multienzyme Complexes Glycogen Protein Serine-Threonine Kinases AMP-Activated Protein Kinases
Authors & Affiliations
15 authors, click to expand affiliations / ORCID
Luptak Ivan
NMR Laboratory for Physiological Chemistry, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, 221 Longwood Avenue, Boston, MA 02115, USA.
Shen Mei
He Huamei
Hirshman Michael F
Musi Nicolas
Goodyear Laurie J
Yan Jie
Wakimoto Hiroko
Morita Hiroyuki
Arad Michael
Seidman Christine E
Seidman J G
Ingwall Joanne S
Balschi James A
Tian Rong
References (49)
49 references, click to expand
  1. Evaluation of carbon flux and substrate selection through alternate pathways involving the citric acid cycle of the heart by 13C NMR spectroscopy.
    J Biol Chem. 1988 May 25;263(15):6964-71 PMID: 3284880
  2. UDP-glucose pyrophosphorylase is upregulated in carriers of the porcine RN- mutation in the AMP-activated protein kinase.
    Proteomics. 2004 Aug;4(8):2448-54 PMID: 15274139
  3. Developmental regulation of myosin gene expression in mouse cardiac muscle.
    J Cell Biol. 1990 Dec;111(6 Pt 1):2427-36 PMID: 2277065
  4. Isolation and characterization of the mouse cardiac myosin heavy chain genes.
    J Biol Chem. 1991 May 15;266(14):9180-5 PMID: 2026617
  5. Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice.
    J Biol Chem. 1991 Dec 25;266(36):24613-20 PMID: 1722208
  6. Nonglucose substrates increase glycogen synthesis in vivo in dog heart.
    Am J Physiol. 1994 Jul;267(1 Pt 2):H219-23 PMID: 8048587
  7. Role of the AMP-activated protein kinase in the cellular stress response.
    Curr Biol. 1994 Apr 1;4(4):315-24 PMID: 7922340
  8. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5'-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase.
    J Biol Chem. 1995 Jul 21;270(29):17513-20 PMID: 7615556
  9. The AMP-activated protein kinase--fuel gauge of the mammalian cell?
    Eur J Biochem. 1997 Jun 1;246(2):259-73 PMID: 9208914
  10. Impaired cardiac energetics in mice lacking muscle-specific isoenzymes of creatine kinase.
    Circ Res. 1998 May 4;82(8):898-907 PMID: 9576109
  11. Mechanisms of control of heart glycolysis.
    Eur J Biochem. 1998 Dec 1;258(2):277-90 PMID: 9874192
  12. Dealing with energy demand: the AMP-activated protein kinase.
    Trends Biochem Sci. 1999 Jan;24(1):22-5 PMID: 10087918
  13. Protein measurement with the Folin phenol reagent.
    J Biol Chem. 1951 Nov;193(1):265-75 PMID: 14907713
  14. GLYCOLYTIC CONTROL MECHANISMS. I. INHIBITION OF GLYCOLYSIS BY ACETATE AND PYRUVATE IN THE ISOLATED, PERFUSED RAT HEART.
    J Biol Chem. 1965 Jun;240:2308-21 PMID: 14304831
  15. The alpha2-5'AMP-activated protein kinase is a site 2 glycogen synthase kinase in skeletal muscle and is responsive to glucose loading.
    Diabetes. 2004 Dec;53(12):3074-81 PMID: 15561936
  16. Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome.
    Circulation. 2005 Jan 4;111(1):21-9 PMID: 15611370
  17. Glycogen storage diseases presenting as hypertrophic cardiomyopathy.
    N Engl J Med. 2005 Jan 27;352(4):362-72 PMID: 15673802
  18. A comparison of three methods of glycogen measurement in tissues.
    Anal Biochem. 1974 Aug;60(2):405-12 PMID: 4844560
  19. Uridine diphosphate glucose synthase from calf liver: determinants of enzyme activity in vitro.
    Biochemistry. 1975 Dec 16;14(25):5445-50 PMID: 172124
  20. N488I mutation of the gamma2-subunit results in bidirectional changes in AMP-activated protein kinase activity.
    Circ Res. 2005 Aug 19;97(4):323-8 PMID: 16051890
  21. Decreased contractile and metabolic reserve in peroxisome proliferator-activated receptor-alpha-null hearts can be rescued by increasing glucose transport and utilization.
    Circulation. 2005 Oct 11;112(15):2339-46 PMID: 16203912
  22. Increased alpha2 subunit-associated AMPK activity and PRKAG2 cardiomyopathy.
    Circulation. 2005 Nov 15;112(20):3140-8 PMID: 16275868
  23. Opposite transcriptional regulation in skeletal muscle of AMP-activated protein kinase gamma3 R225Q transgenic versus knock-out mice.
    J Biol Chem. 2006 Mar 17;281(11):7244-52 PMID: 16410251
  24. Characterization of the role of gamma2 R531G mutation in AMP-activated protein kinase in cardiac hypertrophy and Wolff-Parkinson-White syndrome.
    Am J Physiol Heart Circ Physiol. 2006 May;290(5):H1942-51 PMID: 16339829
  25. Muscle-specific overexpression of wild type and R225Q mutant AMP-activated protein kinase gamma3-subunit differentially regulates glycogen accumulation.
    Am J Physiol Endocrinol Metab. 2006 Sep;291(3):E557-65 PMID: 16638825
  26. Genetic model for the chronic activation of skeletal muscle AMP-activated protein kinase leads to glycogen accumulation.
    Am J Physiol Endocrinol Metab. 2007 Mar;292(3):E802-11 PMID: 17106064
  27. A rapid filter paper assay for UDPglucose-glycogen glucosyltransferase, including an improved biosynthesis of UDP-14C-glucose.
    Anal Biochem. 1968 Oct 24;25(1):486-99 PMID: 5704765
  28. Chronic activation of 5'-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle.
    J Appl Physiol (1985). 1999 Nov;87(5):1990-5 PMID: 10562646
  29. Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart.
    J Clin Invest. 1999 Dec;104(12):1703-14 PMID: 10606624
  30. A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle.
    Science. 2000 May 19;288(5469):1248-51 PMID: 10818001
  31. Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle.
    J Appl Physiol (1985). 2000 Jun;88(6):2219-26 PMID: 10846039
  32. Metabolic stress and altered glucose transport: activation of AMP-activated protein kinase as a unifying coupling mechanism.
    Diabetes. 2000 Apr;49(4):527-31 PMID: 10871188
  33. Glycogen synthase sensitivity to insulin and glucose-6-phosphate is mediated by both NH2- and COOH-terminal phosphorylation sites.
    Diabetes. 2000 Jul;49(7):1096-100 PMID: 10909964
  34. Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia.
    Curr Biol. 2000 Oct 19;10(20):1247-55 PMID: 11069105
  35. Chronic treatment with 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner.
    Diabetes. 2001 Jan;50(1):12-7 PMID: 11147776
  36. Glycogen synthase localization and activity in rat skeletal muscle is strongly dependent on glycogen content.
    J Physiol. 2001 Mar 15;531(Pt 3):757-69 PMID: 11251056
  37. Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis.
    Hum Mol Genet. 2001 May 15;10(11):1215-20 PMID: 11371514
  38. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome.
    N Engl J Med. 2001 Jun 14;344(24):1823-31 PMID: 11407343
  39. Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy.
    Circulation. 2001 Oct 2;104(14):1664-9 PMID: 11581146
  40. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy.
    J Clin Invest. 2002 Feb;109(3):357-62 PMID: 11827995
  41. AMP kinase activation ameliorates insulin resistance induced by free fatty acids in rat skeletal muscle.
    Am J Physiol Endocrinol Metab. 2002 Nov;283(5):E965-70 PMID: 12376323
  42. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury.
    J Clin Invest. 2004 Aug;114(4):495-503 PMID: 15314686
  43. The 5'-AMP-activated protein kinase gamma3 isoform has a key role in carbohydrate and lipid metabolism in glycolytic skeletal muscle.
    J Biol Chem. 2004 Sep 10;279(37):38441-7 PMID: 15247217
  44. Mechanisms for increased glycolysis in the hypertrophied rat heart.
    Hypertension. 2004 Nov;44(5):662-7 PMID: 15466668
  45. Cardiac-specific overexpression of GLUT1 prevents the development of heart failure attributable to pressure overload in mice.
    Circulation. 2002 Oct 15;106(16):2125-31 PMID: 12379584
  46. Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle.
    Am J Physiol Endocrinol Metab. 2003 Apr;284(4):E813-22 PMID: 12488245
  47. Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy.
    Circulation. 2003 Jun 10;107(22):2850-6 PMID: 12782567
  48. Glucose metabolism and energy homeostasis in mouse hearts overexpressing dominant negative alpha2 subunit of AMP-activated protein kinase.
    J Biol Chem. 2003 Aug 1;278(31):28372-7 PMID: 12766162
  49. Analysis of tricarboxylic acid cycle of the heart using 13C isotope isomers.
    Am J Physiol. 1990 Sep;259(3 Pt 2):H987-95 PMID: 1975735
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
2007-05-00
Epub
2007-00-12
Pages
1432-9
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC1847536
Subset
IM
Grants
NHLBI NIH HHS · HL 67970 · United States
NHLBI NIH HHS · R01 HL067970 · United States
NIAMS NIH HHS · AR 45670 · United States
NHLBI NIH HHS · HL 52320 · United States
NHLBI NIH HHS · R29 HL046033 · United States
NHLBI NIH HHS · HL 59246 · United States
NHLBI NIH HHS · HL 46033 · United States
NHLBI NIH HHS · P50 HL052320 · United States
NHLBI NIH HHS · R01 HL046033 · United States
NIDDK NIH HHS · R01 DK068626 · United States
NHLBI NIH HHS · R01 HL059246 · United States
NIAMS NIH HHS · R01 AR045670 · United States
NIDDK NIH HHS · DK 68626 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com